Skip to main content
AVLN logo

AVLN · Avalyn Pharma Inc. · Executive Compensation

Track AVLN — free
$28.22 -0.48 (-1.67%)
Market Cap
$1.28B
Shares
44.52M
Volume · Nov 20 42.1K Avg daily vol (3M) 349.44K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Robert Meyer, M.D. Appointed 2026-09-16

Leadership

Key facts CIK 1540171 CUSIP 05348Y105 13F (30d) 112 filings 110 filers Visit website Investor relations